Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

BI-1206 - Phase 2 | BIOI-B.ST Pipeline | CatalystAlert

Back to BIOI-B.ST

BI-1206

Phase 2

BioInvent International AB (BIOI-B.ST)

15%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Sep 30

BIOI-B.STPhase 2Phase 2

BI-1206 Phase 2 Results Expected

BI-1206 • Indolent B-Cell Non-Hodgkin Lymphoma

Drug Information

Target Indication

Indolent B-Cell Non-Hodgkin Lymphoma

Clinical Trial

Last updated: 12/4/2025

Developer

BIOI-B.ST

BioInvent International AB

Biotechnology•North America•NASDAQ